A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cemiplimab
Related studies linked through entity extraction aliases.
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
- Status
- RECRUITING
- Phase
- PHASE1
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
- Status
- RECRUITING
- Phase
- PHASE2